All the news Showing 10 of 72 articles from: United KingdomGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Screening and testing policy Is opt-out testing for HCV improving testing rates in UK prisons? Keith Alcorn / 04 April 2019 Testing rates for hepatitis C virus (HCV) in prisons in the United Kingdom remain far below the national minimum target of 50% and without radical change, prison testing rates will pose a ... Treatment for people who use drugs HCV reinfection in people who inject drugs a sign of a successful treatment programme, say researchers Keith Alcorn / 11 March 2019 High rates of reinfection in people who inject drugs are a sign that access to treatment is improving, not a sign of failure, and should prompt retreatment, not stigmatisation, Australian hepatitis researcher ... Sex between men Hepatitis C drops among HIV-positive London gay men after direct-acting antiviral scale-up Liz Highleyman / 07 March 2019 New cases of hepatitis C virus (HCV) infection among HIV-positive gay and bisexual men seen at three clinics in London have declined by nearly 70% since 2015, according to a presentation yesterday ... Liver transplants Need for liver transplants due to hepatitis C drops in United Kingdom Keith Alcorn / 22 October 2018 Registrations for liver transplants due to complications of hepatitis C infection in the United Kingdom fell sharply between 2013 and 2016, coinciding with the gradual increase in availability of direct-acting antiviral treatment, researchers ... Hepatitis C elimination Hepatitis C elimination in people living with HIV in the UK is feasible by 2021, British HIV Association says Keith Alcorn / 10 October 2018 Hepatitis C co-infection can be eliminated in people living with HIV in the United Kingdom by 2021, the British HIV Association (BHIVA) said today. “The UK can be the first country to achieve ... Harm reduction interventions and policy Low dead-space syringes associated with lower hepatitis C prevalence in people who inject drugs Keith Alcorn / 01 October 2018 Exclusive use of low dead-space syringes is associated with a lower prevalence of hepatitis C virus (HCV) in people who inject drugs, especially in people who began injecting drugs recently, a study ... Prognosis and disease progression Deaths from end-stage liver disease due to HCV fall in United Kingdom Keith Alcorn / 22 August 2018 Deaths from end-stage liver disease and liver cancer caused by hepatitis C in the United Kingdom fell by 11% in 2017, provisional figures from Public Health England released on 28 July show. Most ... HIV HIV and chronic HCV co-infection prevalence in England highest among MSM Michael Carter / 20 August 2018 Men who have sex with men (MSM) make up the majority of people with chronic hepatitis C virus (HCV) who have co-infection with HIV, according to data from Public Health England (PHE) published ... Harm reduction interventions and policy Scotland’s reduction in new HCV infections due to harm reduction, not treatment Keith Alcorn / 12 June 2018 The reduction in new hepatitis C virus (HCV) infections that has taken place in Scotland since 2008 is most likely due to increased provision of needle and syringe programmes and ... Treatment outcomes Curing hepatitis C reduces deaths and liver disease Keith Alcorn / 17 April 2018 Curing hepatitis C infection significantly reduces deaths from liver disease and reduces the incidence of decompensation, two large prospective studies from Italy and Scotland show. The findings were presented on ... ← Prev1...23456...8Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive